Facioscapulohumeral muscular dystrophy and respiratory failure; what about the diaphragm?  by Hazenberg, A. et al.
lable at ScienceDirect
Respiratory Medicine Case Reports 14 (2015) 37e39Contents lists avaiRespiratory Medicine Case Reports
journal homepage: www.elsevier .com/locate/rmcrCase reportFacioscapulohumeral muscular dystrophy and respiratory failure;
what about the diaphragm?
A. Hazenberg a, b, *, N. van Alfen c, N.B.M. Voet d, H.A.M. Kerstjens a, b, P.J. Wijkstra a, b
a University of Groningen, University Medical Center Groningen, Department of Pulmonology and Tuberculosis, Department of Home Mechanical
Ventilation, Groningen, The Netherlands
b University of Groningen, University Medical Center Groningen, GRIAC Research Institute, The Netherlands
c Department of Neurology and Clinical Neurophysiology, Donders Centre for Neuroscience, Radboud University Nijmegen Medical Centre, Nijmegen,
The Netherlands
d Department of Rehabilitation, Nijmegen Centre for Evidence Based Practice, Radboud University Nijmegen Medical Centre, Nijmegen,
RMC Groot Klimmendaal, Arnhem, The NetherlandsKeywords:
Non invasive positive pressure ventilation
Diaphragm paralysis
Facioscapulohumeral muscular dystrophy
Chronic respiratory failure
SleepAbbreviations: FSHD, facioscapulohumeral muscu
homeobox; PSG, polysomnography; FVC, forced vital
acidity level; paCO2, partial pressure of arterial ca
pressure of arterial oxygen; HCO3, bicarbonate; tcpCO
oxide; SpO2, oxygen saturation; NIPPV, non-invasive
* Corresponding author. University Medical Cente
Home Mechanical Ventilation, Internal code AA 62,
ningen, The Netherlands.
E-mail address: a.hazenberg@umcg.nl (A. Hazenbe
http://dx.doi.org/10.1016/j.rmcr.2014.12.006
2213-0071/© 2014 The Authors. Published by Elseviera b s t r a c t
Introduction: We present a case of facioscapulohumeral muscular dystrophy (FSHD) with a diaphragm
paralysis as the primary cause of ventilatory failure. FSHD is an autosomal dominant inherited disorder
with a restricted pattern of weakness. Although respiratory weakness is a relatively unknown in FSHD, it
is not uncommon.
Methods: We report on the clinical ﬁndings of a 68-year old male who presented with severe dyspnea
while supine.
Results: Supplementing our clinical ﬁndings with laboratory, electrophysiological and radiological per-
formances led to the diagnosis of diaphragm paralysis. Arterial blood gas in sitting position without
supplemental oxygen showed a mild hypercapnia. His sleep improved after starting non-invasive
ventilation and his daytime sleepiness disappeared.
Discussion: We conclude that in patients with FSHD who have symptoms of nocturnal hypoventilation,
an adequate assessment of the diaphragm is recommended. This is of great importance as we know that
nocturnal hypoventilation can be treated effectively by non-invasive ventilation.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Facioscapulohumeral muscular dystrophy (FSHD) is an auto-
somal dominant inherited disorder with a restricted pattern of
weakness and is the third most common form of dystrophy [1]. In
over 95% of the patients a deletion of a 3.3 kb tandem repeat, D4Z4,
on chromosome 4q35 is present (FSHD type 1). In some cases
(FSHD type 2), D4Z4 chromatin relaxation and stable double ho-
meobox (DUX4) expression occur in the absence of D4Z4 array
contraction [2]. FSHD type 1 and 2 are clinically characterized bylar dystrophy; DUX4, double
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Ltd. This is an open access article uasymmetric involvement of muscles in the facial, upper extremity,
trunk and lower extremity region with variable severity (Table 1).
Although respiratory weakness is a relatively unknown feature
of FSHD, it is not uncommon; one study reported that almost all of
the patients will develop restrictive lung disease and 10e20% will
suffer from pulmonary complications (Table 2).
Patients with FSHD may become respiratory insufﬁcient if they
have progressive weakness of respiratory muscles and/or a scoli-
osis, most likely when there are other signs of functionally severe
impairment such as the need to use a wheelchair [4]. In this case
report we present a patient with FSHD who had a diaphragm pa-
ralysis as the primary cause of ventilatory failure.
He was treated successfully with non-invasive positive pressure
ventilation.
Case report
In 2008, at the age of 68, this man was diagnosed with Facio-
scapulohumeral muscular dystrophy (FSHD) type 1 (5 units 4A161).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Ricci score, muscle strengthwas evaluated by using theManual Muscle Testing Scale
[3].
0.5 Facial weakness
1 Mild scapular involvement without limitation of arm abduction;
no awareness of disease symptoms is possible
1.5 Moderate involvement of scapular and arm muscles or both
(arm abduction >60 and strength 3 in arm muscles);
no involvement of pelvic and leg muscles
2 Severe scapular involvement (arm abduction <60 on at least
one side); strength <3 in at least one muscular district of the arms;
no involvement of pelvic and leg muscles
2.5 Tibioperoneal weakness; no weakness of pelvic and proximal
leg muscles
3 Mild weakness of pelvic and proximal leg muscles or both
(strength 4 in all these muscles); able to stand up from a chair
without support
3.5 Moderate weakness of pelvic and proximal leg muscles or both
(strength 3 in all these muscles); able to stand up from a chair
with monolateral support
4 Severe weakness of pelvic and proximal leg muscles or both
(strength <3 in at least one of these muscles); able to stand up
from a chair with double support; able to walk unaided
4.5 Unable to stand up from a chair; walking limited to several steps
with support; may use wheelchair for most activities
5 Wheelchair bound
Table 2
Main clinical ﬁndings [1].
Respiratory symptoms of hypoventilation Hypercapnia
Dyspnea while in supine position
Fatigue
Morning head age
Neuromuscular symptoms Facial muscle weakness
Shoulder girdle weakness
Abdominal muscle weakness
Lower-extremity muscle weakness
Extramuscular symptoms High-frequency hearing loss
Retinal telangiectasias
Atrial arrhythmias
Pain
A. Hazenberg et al. / Respiratory Medicine Case Reports 14 (2015) 37e3938His medical history mentioned also psoriasis, high blood pressure
for which he used bisoprolol, irbesartan, methotrexate and folate.
He had also undergone surgery for penis carcinoma. His ﬁrst
complaints of muscle weakness were noticed at the age of 20
during a physical exam test. Exercise tolerance had been decreasingFig. 1. Nocturnal transcutaneous registration of carbon dioxide (mean 7.8over the last 3e5 years. The last year he experienced severe dys-
pnea when lying in supine position. He was referred to our hospital
to evaluate his respiratory impairment. Normally he slept from
11 PM till 7 AM, did not snore and because of breathlessness in
supine position he preferred to sleep on his side with the top of the
bed in uplift position. In the morning he woke up reasonably ﬁt
without a headache. During daytime he experienced fatigue and
sleepiness, as domany FSHD patients [5,6], and he had to take a nap
every afternoon.
The patient could still walk a short distance and up a ﬂight of
stairs, but this caused shortness of breath, and a mild tachypnea.
On physical examination, his weight was 97 kg, length 1.79 m,
Body Mass index 29.7 kg/m2. He could not lift his arms above
shoulder height. There was atrophy and muscle weakness of
proximal as well as distal upper and lower extremities, back and
abdominal muscles, but no signs of scoliosis. The Ricci score for
clinical severity of FSHD was 3 [3]. Resting heart rate: 70 beats/
minute and resting respiratory rate 18 breaths/minute. In supine
position there was paradoxical abdominal breathing and his res-
piratory rate increased. Arterial blood gas in sitting position
without supplemental oxygen: acidity level (pH) 7.41, partial
pressure of arterial carbon dioxide (paCO2) 6.1 kilopascal (kPa),
partial pressure of oxygen (paO2) 9.7 kPa, bicarbonate (HCO3)
28.6 mmol/l, oxygen-saturation 95%. Nocturnal registration with
the Tosca® transcutaneous monitor, before starting the chronic
ventilatory support, showed amean transcutaneous carbon dioxide
(tcpCO2) of 7.8 kPa (4e6 kPa is normal) and a mean oxygen satu-
ration (SpO2) of 91% (>92% is normal) [7]. The lowest saturationwas
65% (Fig. 1).
To exclude that the patient had an obstructive sleep apnea
syndrome a polysomnography (PSG) was performed [5,8,9]. The
PSG showed a disturbed sleep with short awakenings and an ap-
nea/hypopnea index of 2/hour (<5 is normal). Pulmonary function
tests showed a decline in forced vital capacity (FVC) of 1.5 L when
moving from sitting to supine position: FVC sitting 2.60 L (59%
predicted), in supine position 1.10 L (25% predicted). Fluoroscopy of
the diaphragm in supine position during a sniff maneuver revealed
paradoxical diaphragm movement on both sides.
Results
To relieve his physical complaints and improve his alveolar
hypoventilation he started non-invasive positive pressurekPa) and oxygen saturation (mean 91%) before starting ventilation.
Fig. 2. There is a relevant improvement in carbon dioxide (mean 6.1 kPa) and oxygen saturation levels (mean 94%) during ventilatory support.
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pressure assisted controlled mode with an inspiratory pressure of
24 cm H2O, a positive end expiratory pressure of 8 cm H2O and a
frequency of 15 per minute. The patient used the ventilator every
night with a mean usage of 7 h per night. His relationship with the
ventilator was dual; he thought of it as an enemy because he had
problems accepting the necessity to be ventilated, but also as a
friend because it provided him better sleep andmore energy during
the day. While the vital capacity did not change after starting
NIPPV, the arterial blood gas during the day at rest without venti-
lation did improve: pH 7.41, pCO2 5.9 kPa, pO2 11 kPa, HCO3
28 mmol/l, oxygen-saturation 97%. Nocturnal registration one year
after starting the NIPPV showed a mean tcpCO2 of 6.1 kPa and a
mean SpO2 of 94% (Fig. 2).
By using NIPPV the patient could now sleep in supine position.
He slept better and he experienced more energy during daily ac-
tivities. In addition he did not fall asleep anymore during daytime
hours.
Discussion
This patient with FSHD had respiratory failure due to bilateral
diaphragm paralysis as shown by the large drop in the vital capacity
when changing from sitting to supine position in combinationwith
paradoxical diaphragm movement during the sniff maneuver. A
recent study concluded that the diaphragm should in principle not
be paralyzed in patients with FSHD and therefore the authors did
not recommend an evaluation of the diaphragm [10]. However, in
that study patients were included who did not have symptoms of
hypoventilation like morning headache, fatigue and daytime
sleepiness, so it could be expected that the lung function was only
mildly impaired. It is known that patients with FSHD can have
complaints due to hypoventilation [4]. As an assessment of the vital
capacity in both sitting and supine position and ﬂuoroscopy of the
diaphragm was not mentioned in that study, a paralysis of the
diaphragm could have been missed as the primary cause of hypo-
ventilation. Actual search and documentation of nocturnal hypo-
ventilation is relevant since it can be treated effectively by NIPPV.
We conclude that in patients with FSHD, who have symptoms of
nocturnal hypoventilation such as morning headache, fatigue anddaytime sleepiness, an adequate assessment of the diaphragm is
recommended.
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